John Benson
Directeur Financier/CFO chez PATHFINDER CELL THERAPY, INC.
Postes actifs de John Benson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PATHFINDER CELL THERAPY, INC. | Directeur Financier/CFO | 29/09/2011 | - |
| Treasurer | 04/06/2013 | - | |
| Directeur/Membre du Conseil | 29/09/2011 | 24/05/2012 | |
| Secrétaire Général | 29/09/2011 | 04/06/2013 |
Historique de carrière de John Benson
Anciens postes connus de John Benson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
SyntheMed, Inc.
 SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Comptroller/Controller/Auditor | 01/09/2006 | 16/09/2011 |
| Pathfinder LLC | Directeur Financier/CFO | - | 16/09/2011 |
| Treasurer | - | 16/09/2011 | |
| STRYKER CORPORATION | Corporate Officer/Principal | 01/01/2003 | - |
Formation de John Benson
| St. Bonaventure University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Director of Finance/CFO | 2 |
| Treasurer | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| STRYKER CORPORATION | Health Technology |
| PATHFINDER CELL THERAPY, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Health Technology |
| Pathfinder LLC | Health Technology |
- Bourse
- Insiders
- John Benson
- Expérience
